News

Greenway Health Expands Leadership for Growth and Innovation

Greenway Health Expands Leadership for Growth and Innovation

Strategic Leadership Appointments at Greenway Health

Greenway Health is making notable advancements in its Go-To-Market strategy by welcoming two experienced sales leaders to the team. This strategic move aims to boost customer acquisition and expand the company's presence in the healthcare technology sector.

Introducing Geordie Sanborn, New Vice President of Sales

Geordie Sanborn joins Greenway Health as the new Vice President of Sales, bringing with him extensive experience in the healthcare IT industry. Previously, he focused on healthcare growth and strategy at Arvest Bank. Before that, he was the Senior Vice President at Bank of America, where he was instrumental in the acquisition of AxiaMed. Sanborn also spent nearly 13 years at eClinicalWorks, holding senior sales leadership roles during a period of rapid growth.

In his new position at Greenway, Sanborn will oversee the New Logo and Field Sales teams. His key goals include driving new customer acquisition and enhancing field sales operations, both vital for increasing the company’s influence in important markets.

Welcoming Chuck Rackley to the Leadership Team

Chuck Rackley, an expert in healthcare technology, has been appointed as Vice President of Sales, with a focus on revenue cycle management solutions. He has a proven track record from his previous role as Chief Strategy Officer at Infinx, where he successfully implemented strategic sales initiatives that increased market share.

At Greenway, Rackley’s expertise will be essential for scaling growth in revenue cycle management and refining sales operations. His appointment underscores the company’s commitment to enhancing its ability to deliver innovative solutions to healthcare providers.

Strategic Vision for the Future

In discussing these appointments, Pratap Sarker, CEO of Greenway Health, reaffirmed the company's dedication to ongoing growth. He pointed out the recent investments in their go-to-market strategy, which includes recruiting key leadership positions to meet the needs of clients and patients. The addition of Sanborn and Rackley represents a strategic move to deepen the company’s leadership, which is crucial for achieving growth targets and fostering innovation in healthcare solutions.

Commitment to Healthcare Providers

The new executives at Greenway Health are set to play vital roles in tackling the challenges faced by healthcare providers. By minimizing administrative burdens, addressing staffing shortages, and alleviating clinician burnout, these leaders are well-positioned to drive improvements that will directly benefit healthcare practitioners and their patients.

With a strong emphasis on innovation, the company is expanding its range of AI-driven solutions, including Greenway Clinical Assist™, Greenway Patient Connect™, Greenway Document Manager™, and Electronic Case Reporting (eCR). This initiative highlights Greenway’s commitment to providing advanced tools that enhance operational efficiencies and improve patient care.

About Greenway Health

Greenway Health is recognized as a leader in health information technology, specializing in electronic health records through its flagship products, Intergy and Prime Suite. The organization’s dedication to quality service has earned it high rankings in KLAS Research, an independent organization that evaluates healthcare vendor performance based on user feedback.

Additionally, Greenway's revenue cycle solution, Greenway Revenue Services, was honored with the 2023 North American Customer Value Leadership Award in Frost & Sullivan's Best Practices Award category. Greenway Health is committed to empowering healthcare providers with the tools they need to succeed in a complex and evolving healthcare landscape.

For more details about Greenway Health's innovative solutions and services, please call 877-537-0063 or connect with the company on its social media platforms.

Frequently Asked Questions

What is Greenway Health's focus area?

Greenway Health specializes in electronic health records and various healthcare technology solutions aimed at improving provider efficiencies and patient care.

Who are the newly appointed leaders at Greenway Health?

The new leaders are Geordie Sanborn, who serves as Vice President of Sales, and Chuck Rackley, who has taken on the role of Vice President of Sales, focusing on revenue cycle management.

What role will the new sales leaders play?

They will be responsible for expanding customer acquisition, optimizing sales operations, and driving overall market growth for Greenway Health's innovative solutions.

How does Greenway Health support its clients?

Greenway Health provides cutting-edge tools designed to reduce administrative burdens, improve efficiencies, and enhance patient care across healthcare practices.

What recognition has Greenway Health received?

Greenway Health has been highly ranked in KLAS Research for its health solutions and has recently won the 2023 North American Customer Value Leadership Award.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 6

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 21

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 7

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 6

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 6

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 3

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading

Top 5 Most Recently Viewed Articles

Key Financial Trends Shaping Markets for Investors in 2025

Updated Category News Views 667

Global Financial Markets Prepare for 2025 Global financial markets are gearing up for an important year ahead. As we approach 2025, significant changes in currency markets and commodity prices are predicted to present both challenges and opportunities for investors, traders, and market analysts. This article delves into five major themes expected to shape the financial...

Continue Reading
Exploring Synovus Financial Inc's Earnings Potential and Metrics

Updated Category News Views 194

Understanding Synovus Financial Inc's Current Stock Performance In today's market, Synovus Financial Inc. (NYSE: SNV) is priced at $45.89, reflecting a 1.30% rise. However, the recent history shows a decline, with the stock falling by 7.83% over the last month and 6.52% over the past year. This fluctuation raises questions among shareholders about the stock's potential...

Continue Reading
Buffett's Strategic Exit from Key ETFs: Analyzing Implications

Updated Category News Views 387

Buffett's Recent Moves in the ETF Landscape Recently, Berkshire Hathaway made headlines as it divested from two key S&P 500 ETFs, including the Vanguard S&P 500 ETF, the largest of its kind globally. This bold decision has raised eyebrows in the investment community, leading many to ponder what insights this could offer into the mind of Warren Buffett, often revered as...

Continue Reading
Global Partnership Enhances Remote Employee Verification Solutions

Updated Category News Views 105

Sumsub and TELUS Digital: A Powerful Partnership In today's rapidly evolving digital landscape, securing the workforce has never been more critical. With companies expanding their reach globally, the need for streamlined processes in employee verification and onboarding has risen to the forefront. Sumsub, a renowned full-cycle verification platform, has joined forces with...

Continue Reading
Analyzing Palantir Technologies' Latest Developments and Trends

Updated Category News Views 162

Palantir Expands PFCS Forward Authorization Palantir Technologies is making significant strides with its PFCS Forward, which has recently broadened its Provisional Authorizations for Impact Level 5 and Impact Level 6 to encompass both on-premises and edge deployments. This strategic move facilitates a more versatile implementation of its technology across numerous...

Continue Reading